Zevra Therapeutics is a nimble rare disease therapeutics company that is dedicated to bringing new therapies to patients. With a proven track record, they are committed to overcoming drug development and regulatory challenges to make life-changing therapeutics available to people with rare diseases. Their mission is to give every promising rare disease therapy candidate a fighting chance to reach patients and improve their quality of life.

Zevra Therapeutics involves key thought leaders, physicians, patients, care partners, and advocacy groups in all of their clinical and regulatory development strategies. By following the data without bias, they have successfully overcome complex development challenges to make much-needed therapies available. Their transparent narratives and common-sense perspective have allowed them to forge new pathways to success that others have overlooked.

Nimble and dauntless, Zevra pushes boundaries beyond what is thought to be possible and advances new therapies that have the potential to bring meaningful improvement to patients' lives. Through their dedication and expertise, Zevra Therapeutics is making a significant impact in the field of rare disease therapeutics